ArticleNano letters2025
Integrated Methodology from Synthesis to
Article in Nano letters, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Condensate corona-nanoparticle complexes transfer functional biomolecules between cells.Nature materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A new integrated tunable microfluidic particle synthesis and shape population analysis workflow allows us to study the immunological readouts for even highly complex shaped nanoparticles. Using this approach, we demonstrate that some gold nanoparticles, when injected parenterally, are taken up by axillary and brachial lymph nodes. We then show that specific nanoparticle shapes influence the primary structure of the T cell receptor, inducing changes in hypervariable complementary-determining regions (CDRs) and increasing the clonal diversity of the T cell receptor repertoires. These same particles were previously found to modify cellular epigenomes and elevate the level of autoantibodies. Our results are consistent with other emerging reports that precisely controlled nanoarchitectural features are recognized and captured in multiple tiers of biology, with potential implications for vaccine adjuvant design. Our conclusions may also be relevant to an extensive legacy of poorly understood epidemiological studies, suggesting links between some pollutant particulates and complex forms of immune dysregulation and autoimmune diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.